Search

everythinglearnresearchcommunity

for

Search:↓

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

PNKP is essential for keeping adult mouse progenitor cells healthy and growing normally.

Protein kinase C epsilon may promote skin cancer development after UV exposure by affecting nearby cells.

Anabolic steroids boost muscle growth, SARMs increase muscle mass and bone density without side effects, and myostatin inhibitors block a protein that stops muscle growth, but each has potential risks.

The study found that androgen receptors in skin cells mainly affect the focal adhesion pathway and control the caveolin-1 gene, with implications for new treatments for related diseases.

New treatments for hair loss show promise but need more testing for effectiveness and safety.

A new method helps detect androgen receptor movement in cells, aiding research on hair loss treatments.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

The conclusion is that adult males with muscle weakness and hormonal imbalances should be tested for Kennedy's disease.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

pH changes are crucial for root hair growth because they affect enzymes and proteins that control the cell wall and growth.

Gray hair can potentially be reversed, leading to new treatments.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

Maintaining DNA health in stem cells is key to preventing aging and tissue breakdown.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

XEDAR triggers a specific signaling pathway in cells.

Altered metabolism can help control seizures by changing brain signaling and energy use, suggesting new treatments for epilepsy.

Nucleic acids trigger chemokine production in skin cells, affecting skin inflammation.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Rituximab can cause skin issues, but baricitinib may help improve them.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.